Inappropriate prescribing in geriatric patients

Current Psychiatry Reports

Volumn 10, Issue 1, 2008, Pages 37-43

  Barry, Patrick J ^a   Gallagher, Paul ^b   Ryan, Cristin ^b  

^a University College Cork and INFANT Centre   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANTACID AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; DIAZEPAM; DULOXETINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; IRON DERIVATIVE; METFORMIN; NEUROLEPTIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYBUTYNIN; PROPANTHELINE BROMIDE; QUINOLONE DERIVATIVE; ROFECOXIB; ROSIGLITAZONE; SPIRONOLACTONE; SULFONYLUREA; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGED; AGGRESSIVENESS; ARTHRITIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; DELIRIUM; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG USE; DRUG WITHDRAWAL; DYSLIPIDEMIA; EXTRAPYRAMIDAL SYMPTOM; FALLING; GASTROINTESTINAL HEMORRHAGE; GERIATRIC CARE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HIP FRACTURE; HUMAN; HYPERTENSION; INSOMNIA; ISCHEMIC COLITIS; KIDNEY BLOOD FLOW; LOW DRUG DOSE; MEDICATION ERROR; NAUSEA; ORTHOSTATIC HYPOTENSION; POLYPHARMACY; POTASSIUM BLOOD LEVEL; PRESCRIPTION; REVIEW; SIDE EFFECT; SLEEP DISORDER; UNSPECIFIED SIDE EFFECT; URINE INCONTINENCE; XEROSTOMIA;

ACCIDENTAL FALLS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOTRANSFORMATION; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOGLYCEMIC AGENTS; MOBILITY LIMITATION; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PSYCHOTROPIC DRUGS; RISK FACTORS; SLEEP DISORDERS; THIAZOLIDINEDIONES; TREATMENT OUTCOME;

EID: 39449115080     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-008-0008-3     Document Type: Review

References (50)

1. Golden AG, Preston RA, Barnett SD, et al.: Inappropriate prescribing in homebound older adults. J Am Geriatr Soc 1999, 47:948-953
2. O'Connor K, O'Mahony D: Drugs and ageing. In Medicine for Older Patients: Cases and Practice. Edited by Liston R, Mulkerrin EC. Dublin, Ireland: Eireann Healthcare Publications; 2003:205.
3. Kaufman DW, Kelly JP, Rosenberg L, et al.: Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 2002, 287:337.
4. Everitt DE, Avorn J: Drug prescribing for the elderly. Arch Intern Med 1986, 146:2393-2396.
5. Mangoni AA, Jackson SH: Age-related changes in pharmacokinetics and pharmacodynarnics: basic principles and practical applications. Br J Clin Pharmacol 2003, 57:6-14.
6. Hunt CM, Westerkam WR, Stave GM: Effect of age and gender on the activity of human hepatic CYP3A. Biocbem Pharmacol 1992, 44:275.
7. Swift CG, Ewen JM, Clarke P, Stephenson IH: Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations. Br J Clin Pharmacol 1985, 20:111-118.
8. Maixner SM, Mellow AM, Tandon R: The efficacy, safety and tolerability of antipsychotics in the elderly. J Clin Psychiatry 1999, 60:29-41.
9. Col N, Fanale JE, Kronholm P: The role of medication non-compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990, 150:841-845.
10. Hanlon JT, Schmader KE, Kornkowski MJ, et al.: Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997, 45:945-948.
11. Lindley CM, Tully MP, Paramsothy V, et al.: Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992, 21:294-300.
12. Cooper JW: Adverse drug reaction-related hospitalizations of nursing-facility patients: a 4 year study. South Med J 1999, 92:485-490.
13. Fick DM, Cooper JW, Wade WE, et al.: Updating the Beers criteria for potentially inappropriate medication use in older adults-results of a US consensus panel of experts. Arch Intern Med 2003, 163:2716-2724.
14. McLeod PJ, Huang AR, Tamblyn RN, Gayton DC: Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997, 156:385-391.
15. Naugler CT, Brymer C, Stolee P, Arcese ZA: Development and validation of an improved prescribing for the elderly tool. Can J Clin Pharmacol 2000, 7:103-107.
16. Laroche ML, Charmes JP, Merle L: Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007, 63:725-731.
17. Oborne CA, Hooper R, Swift CG, Jackson SH: Explicit, evidence-based criteria to assess the quality of prescribing to elderly nursing home residents. Age Ageing 2003, 32:102-108.
18. Liu GG, Christensen DB: The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash) 2002, 42:847-857.
19. Pitkala KH, Strandberg TE, Tilvis RS: Inappropriate drug prescribing in home-dwelling elderly patients: a population based survey. Arch Intern Med 2002, 162:1707-1712.
20. Hanlon JT, Schmader KE, Samsa GP, et al.: A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992, 45:1045-1051.
21. Jeffrey S, Ruby C, Tverlisky J, et al.: Effect of an interdisciplinary team on suboptimal prescribing in a long-term care facility. Consult Pharm 1999, 14:1386-1391.
22. Hanlon JT, Artz MB, Pieper CF, et al.: Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004, 38:9-14.
23. Higashi T, Shekelle PG, Solomon DH: The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004, 140:714-720.
24. Spinewine A, Schmader KE, Barber N, et al.: Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007, 370:173-184.
25. Lord SR, Anstey KJ, Williams P, et al.: Psychoactive medication use, sensory motor function and falls in older women. Br J Clin Pharmacol 1995, 39:227-234.
26. Souchet E, Lapeyre-Mestre M, Montastruc JL: Drug related falls: a study in the French Pharmacovigilance database. Pharmacoepidemiol Drug Saf 2005, 14:11-16.
27. Kamal-Bahl SJ, Stuart BC, Beers MH: Propoxyphene use and risk for hip fracture in older adults. Am J Geriatr Pharmacother 2006, 4:219-226.
28. Crotty M, Rowett D, Spurling L, et al.: Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004, 2:25-64.
29. Herzog AR, Fultz NH: Prevalence and incidence of urinary incontinence in community dwelling populations. J Am Geriatr Soc 1990, 38:273-281.
30. Wagner TH, Hu TW: Economic costs of urinary incontinence in 1995. Urology 1998, 51:355-361.
31. Hay-Smith J, Herbison P, Ellis G, et al.: Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev 200S, 3:CD005429.
32. Gill SS, Mamdani M, Naglie G, et al.: A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 2005, 165:808-813.
33. Gahimer J, Wernicke J, Yalcin I, et al.: A retrospective pooled analysis of duloxetine safety in 23,983 subjects. Curr Med Res Opin 2007, 23:175-184.
34. Wang PS, Schneeweiss S, Avorn J, et al.: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005, 353:2335-2341.
35. Bullock R: Treatment of behavioral and psychiatric symptoms in dementia: implications of recent safety warnings. Curr Med Res Opin 2005, 21:1-10.
36. Zanocchi M, Tibaldi V, Amati D, et al.: Adverse drug reactions as a cause of visits to the emergency department: incidence, features and outcome [in Italian]. Recenti Prog Med 2006, 97:381-388.
37. Galatti L, Giustini SE, Sessa A, et al.: Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy. Pharmacol Res 2005, 51:211-216.
38. Karacan I, Thornby JT, Williams RL: Sleep disturbance: a community survey. In Sleep/Wake Disorders: A Natural History, Epidemiology and Long Term Evolution. Edited by Guilleminault C, Lugaresi E. New York: Raven Press; 1983:37-60.
39. Huang WF, Lai IC: Potentially inappropriate prescribing for insomnia in elderly outpatients in Taiwan. Int J Clin Pharmacol Ther 2006, 44:335-342.
40. Swegle JM, Logemann C: Management of common opioid side effects. Am Fam Physician 2006, 74:1347-1354.
41. Heading R, Bardhan K, Hollerbach S, et al.: Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome - a European perspective. Aliment Pharmacol Ther 2006, 24:207-236.
42. Currow DC, Stevenson JP, Abernethy AP, et al.: Prescribing in palliative as death approaches. J Am Geriatr Soc 2007, 55:590-595.
43. Ratz Bravo AE, Tchambaz L, Krahenbuhl-Melcher A, et al.: Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy. Drug Saf 2005, 28:263-275.
44. Muldoon MF, Ryan CM, Sereika SM, et al.: Randomized trial of the effects of sinivastatin on cognitive functioning in hypercholesterolemic adults. Am J Med 2004, 117:823-829.
45. Tatley M, Savage R: Psychiatric adverse reactions with statins, fibrates and ezetimibe. Drug Saf 2007, 30:195-201.
46. Ko DT, Juurlink DN, Mamdani MM, et al.: Appropriateness of spironolactone prescribing in heart failure patients: a population-based study. J Card Fail 2006, 12:205-210.
47. Gallelli L, Colosimo M, Pirritano D, et al.: Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs. Clin Drug Investig 2007, 27:115-122.
48. Bresalier RS, Sandier RS, Quan H, et al.: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352:1092-1102.
49. Nissen SE, Wolski K: Effects of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007, 356:2457-2471.
50. Home PD, Pocock SJ, Beck-Nielsen H, et al.: Rosiglitazone evaluated for cardiovascular outcomes - an interim analysis. N Engl J Med 2007, 357:28-38.